Read More 1 minute read Analyst Color Analyst Ratings Downgrades Price Target Why This 10X Genomics Analyst Is Turning Bearish, Slashing Price Target By Priya Nigam July 15, 11:29 AM 10X Genomics Inc (NASDAQ: TXG) reported preliminary second-quarter revenues Thursday that were meaningfully below the consensus estimates. TXG
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on Lennox International, Lowers Price Target to $222 By Benzinga Newsdesk July 15, 11:25 AM Morgan Stanley analyst Joshua Pokrzywinski maintains Lennox International (NYSE:LII) with a Equal-Weight and lowers the price target from $238 to $222. LII
Read More 3 minute read Analyst Ratings Earnings News Will Strong Demand Drive Steel Dynamics’ (STLD) Q2 Earnings? By Zacks July 15, 11:24 AM Steel Dynamics, Inc. STLD is set to release second-quarter 2022 results after the closing bell on Jul 20. CE
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Overweight on Legend Biotech, Raises Price Target to $63 By Benzinga Newsdesk July 15, 11:22 AM Morgan Stanley analyst Matthew Harrison maintains Legend Biotech (NASDAQ:LEGN) with a Overweight and raises the price target from $55 to $63. LEGN
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on Latham Group, Lowers Price Target to $8 By Benzinga Newsdesk July 15, 11:19 AM Morgan Stanley analyst Joshua Pokrzywinski maintains Latham Group (NASDAQ:SWIM) with a Equal-Weight and lowers the price target from $12 to $8. SWIM
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on Kimco Realty, Lowers Price Target to $22 By Benzinga Newsdesk July 15, 11:16 AM Morgan Stanley analyst Richard Hill maintains Kimco Realty (NYSE:KIM) with a Equal-Weight and lowers the price target from $25 to $22. KIM
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Overweight on Invitation Homes, Lowers Price Target to $40.5 By Benzinga Newsdesk July 15, 11:14 AM Morgan Stanley analyst Richard Hill maintains Invitation Homes (NYSE:INVH) with a Overweight and lowers the price target from $42.5 to $40.5. INVH
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on Intuitive Surgical, Lowers Price Target to $225 By Benzinga Newsdesk July 15, 11:11 AM Morgan Stanley analyst Cecilia Furlong maintains Intuitive Surgical (NASDAQ:ISRG) with a Equal-Weight and lowers the price target from $300 to $225. ISRG
Read More 1 minute read Analyst Ratings What 10 Analyst Ratings Have To Say About DexCom By Benzinga Insights July 15, 11:07 AM DexCom (NASDAQ:DXCM) has observed the following analyst ratings within the last quarter: DXCM
Read More 1 minute read Analyst Ratings Expert Ratings for Alnylam Pharmaceuticals By Benzinga Insights July 15, 11:03 AM Analysts have provided the following ratings for Alnylam Pharmaceuticals (NASDAQ:ALNY) within the last quarter: ALNY